Patents by Inventor Saireudee Chaturantabut

Saireudee Chaturantabut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTAGONISTIC BIPARATOPIC ANTIBODIES THAT SPECIFICALLY BIND FIBROBLAST GROWTH FACTOR RECEPTOR 2 AND METHODS OF USING SAME
    Publication number: 20230295308
    Abstract: Described and featured herein are antagonistic biparatopic antibodies that specifically bind and inhibit an FGF receptor (e.g., FGFR2) and methods of using such antibodies for the treatment of cancers, including Cholangiocarcinoma (CCAs).
    Type: Application
    Filed: June 2, 2021
    Publication date: September 21, 2023
    Applicants: The Broad Institute, Inc., Dana-Farber Cancer Institute, Inc.
    Inventors: Saireudee CHATURANTABUT, William SELLERS
  • Estrogen sensing through GPER1 regulates normal and malignant liver growth
    Patent number: 11040054
    Abstract: Provided herein are methods for the prevention and treatment of an abnormal tissue condition in the liver (e.g., liver cancer) of a subject, based on the administration of an inhibitor of a G protein-coupled estrogen receptor 1 (GPER1).
    Type: Grant
    Filed: November 14, 2017
    Date of Patent: June 22, 2021
    Assignee: The Brigham and Women's Hospital, Inc.
    Inventors: Wolfram Goessling, Saireudee Chaturantabut
  • Estrogen Sensing Through GPER1 Regulates Normal and Malignant Liver Growth
    Publication number: 20190314399
    Abstract: Provided herein are methods for the prevention and treatment of an abnormal tissue condition in the liver (e.g., liver cancer) of a subject, based on the administration of an inhibitor of a G protein-coupled estrogen receptor 1 (GPER1).
    Type: Application
    Filed: November 14, 2017
    Publication date: October 17, 2019
    Inventors: Wolfram Goessling, Saireudee Chaturantabut